非神经元胆固醇系统对炎症性皮肤疾病的治疗干预措施的影响
Hui-Qi Qu1, Charlly Kao1, Hakon Hakonarson1,2,3,4,5
1The Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Experimental dermatology
|October 18, 2024
概括
乙胆 (ACh) 在神经系统和皮肤细胞内的非神经胆系统 (NNCS) 中发挥关键作用. 了解皮肤中的NNCS对于治疗皮肤病和开发新疗法至关重要.
科学领域:
- 神经科学是一个神经科学.
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 乙胆 (ACh) 是一种重要的神经递质,在神经系统中具有既定的作用.
- 新出现的证据突出显示了非神经胆固醇系统 (NNCS) 在各种生理过程中的重要性,包括皮肤生物学.
研究的目的:
- 提供ACh合成,释放,受体相互作用和降解的全面审查.
- 探索NNCS在皮肤细胞中的多方面的作用及其对皮肤健康和疾病的影响.
- 讨论针对皮肤疾病的NNCS治疗策略.
主要方法:
- 文献综述侧重于神经系统和皮肤中的ACh和NNCS.
- 分析NNCS在角质细胞,内皮细胞,纤维细胞,免疫细胞和其他皮肤部件中的功能.
- 在皮肤病学中检查调节胆固醇信号的治疗剂.
主要成果:
- NNCS对于表皮屏障完整性,伤口愈合,微循环和皮肤炎症反应至关重要.
- NNCS的失调与各种皮肤疾病的发病有关,包括牛皮,亚托皮炎和.
- 一些治疗策略,如ACHE抑制剂和受体调节器,显示出皮肤病学应用的潜力.
结论:
- 该NNCS是皮肤局部ACH调节的有希望的治疗点.
- 需要进一步的研究,特别是全面的人体研究,以克服胆固醇信号的复杂性,并将研究结果转化为临床实践.
- 在皮肤健康和疾病中更深入地了解NNCS将推动皮肤病学的未来治疗创新.
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
618
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
618
Direct-Acting Cholinergic Agonists: Therapeutic Uses
693
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
693
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.2K
Cholinergic Antagonists: Therapeutic Uses
717
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
717
Cholinergic Antagonists: Pharmacological Actions
1.0K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.0K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.1K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.1K


